Lifestyles, risk factors and prevention of oncological diseases: the role of the cardiologist

被引:1
作者
Abrignani, Maurizio G. [1 ]
Parrini, Iris [2 ]
Grosseto, Daniele [3 ]
Lestuzzi, Chiara [4 ]
Mistrangelo, Marinella [5 ]
Passaretti, Bruno [6 ]
机构
[1] POS Antonio Abate, UO Cardiol, Trapani, Italy
[2] Osped Mauriziano Umberto 1, SC Cardiol, Turin, Italy
[3] Osped Infermi, UO Cardiol, Rimini, Italy
[4] AAS 5 Friuli Occidentale, Cardiol Riabilitat, Ctr Riferimento Oncol, Aviano, RN, Italy
[5] Citta Salute & Sci, Dipartimento Rete Oncol Piemonte & Valle Aosta, Turin, Italy
[6] Humanitas Gavazzeni, UO Riabilitaz, Bergamo, Italy
关键词
Cancer; Cardiovascular disease; Prevention; Risk factors; LUNG-CANCER RISK; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; MEDITERRANEAN DIET; SMOKING-CESSATION; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; PROSTATE-CANCER; MANAGEMENT PATHWAYS; CONSENSUS DOCUMENT;
D O I
10.1714/3079.30717
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although commonly thought of as two separate disease entities, cardiovascular diseases and cancer, the leading causes of death, possess various possible interactions, including a number of similar risk factors (e.g. obesity, diabetes, chronic inflammation). Each cardiologist should provide counseling for a correct lifestyle (diet, physical exercise, avoiding smoking and alcohol abuse); doing so, not only cardiovascular diseases, but also cancer could be prevented. Besides, intervention on diet, physical activity and smoking has been shown to be effective even in patients with known cancers. Many drugs used in cardiovascular prevention (i.e. aspirin, metformin, statins, and beta-blockers) have shown in vivo and in vitro promising pleiotropic properties, and, in observational studies, they were also effective in the prevention of some cancers, although this matter is controversial, emphasizing the need for interventional studies in the field of primary and secondary cancer prevention. Considerable interest has emerged regarding the potential adjuvant chemotherapeutic use of these drugs, but real-world epidemiological data remain inconclusive. In this review, we explore the risk factors common to both cardiovascular diseases and cancer, as well as the role of preventive cardiology treatments, highlighting the related major epidemiologic studies and potential biological mechanisms.
引用
收藏
页码:20 / 31
页数:12
相关论文
共 125 条
[1]  
Abdelgadir Elamin, 2017, J Clin Med Res, V9, P388, DOI 10.14740/jocmr2922e
[2]   Enhancing the Effectiveness of Smoking Cessation Interventions: A Cancer Prevention Imperative [J].
Alberg, Anthony J. ;
Carpenter, Matthew J. .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (04) :260-+
[3]   The current evidence on statin use and prostate cancer prevention: are we there yet? [J].
Alfaqih, Mahmoud A. ;
Allott, Emma H. ;
Hamilton, Robert J. ;
Freeman, Michael R. ;
Freedland, Stephen J. .
NATURE REVIEWS UROLOGY, 2017, 14 (02) :107-119
[4]   The Role of Common Pharmaceutical Agents on the Prevention and Treatment of Pancreatic Cancer [J].
Amin, Sunil ;
Boffetta, Paolo ;
Lucas, Aimee L. .
GUT AND LIVER, 2016, 10 (05) :665-671
[5]  
[Anonymous], Cancer
[6]   Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC) [J].
Augustin, L. S. A. ;
Kendall, C. W. C. ;
Jenkins, D. J. A. ;
Willett, W. C. ;
Astrup, A. ;
Barclay, A. W. ;
Bjorck, I. ;
Brand-Miller, J. C. ;
Brighenti, F. ;
Buyken, A. E. ;
Ceriello, A. ;
La Vecchia, C. ;
Livesey, G. ;
Liu, S. ;
Riccardi, G. ;
Rizkalla, S. W. ;
Sievenpiper, J. L. ;
Trichopoulou, A. ;
Wolever, T. M. S. ;
Baer-Sinnott, S. ;
Poli, A. .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (09) :795-815
[7]   Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies [J].
Aune, Dagfinn ;
Keum, NaNa ;
Giovannucci, Edward ;
Fadnes, Lars T. ;
Boffetta, Paolo ;
Greenwood, Darren C. ;
Tonstad, Serena ;
Vatten, Lars J. ;
Riboli, Elio ;
Norat, Teresa .
BMC MEDICINE, 2016, 14
[8]   Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis [J].
Bagnardi, V. ;
Rota, M. ;
Botteri, E. ;
Tramacere, I. ;
Islami, F. ;
Fedirko, V. ;
Scotti, L. ;
Jenab, M. ;
Turati, F. ;
Pasquali, E. ;
Pelucchi, C. ;
Galeone, C. ;
Bellocco, R. ;
Negri, E. ;
Corrao, G. ;
Boffetta, P. ;
La Vecchia, C. .
BRITISH JOURNAL OF CANCER, 2015, 112 (03) :580-593
[9]   Physical Activity, Biomarkers, and Disease Outcomes in Cancer Survivors: A Systematic Review [J].
Ballard-Barbash, Rachel ;
Friedenreich, Christine M. ;
Courneya, Kerry S. ;
Siddiqi, Sameer M. ;
McTiernan, Anne ;
Alfano, Catherine M. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (11) :815-840
[10]   Incidence of cancer in patients with chronic heart failure: a long-term follow-up study [J].
Banke, Ann ;
Schou, Morten ;
Videbaek, Lars ;
Moller, Jacob E. ;
Torp-Pedersen, Christian ;
Gustafsson, Finn ;
Dahl, Jordi S. ;
Kober, Lars ;
Hildebrandt, Per R. ;
Gislason, Gunnar H. .
EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (03) :260-266